Consistent with the results of previous animal studies, the investigation of the cell insulin signaling pathway suggested that the H-L + HFD-induced liver fibrosis was mediated by gut microbiota through disruption of the gut barrier TLR4/MYD88 and liver IRS1/Akt/mTOR signaling pathways. This evidence concerns the gene MYD88 and Hepatic fibrosis.